XML 39 R29.htm IDEA: XBRL DOCUMENT v3.25.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration risks (Details)
3 Months Ended 9 Months Ended
Sep. 13, 2024
Sep. 30, 2025
USD ($)
customer
Sep. 30, 2024
USD ($)
customer
Sep. 30, 2025
USD ($)
customer
Sep. 30, 2024
USD ($)
customer
Concentration risks          
Aggregate dollar amount of net sales   $ 10,085,723 $ 10,346,857 $ 28,826,629 $ 23,975,584
Syringes and needles          
Concentration risks          
Additional percentage of tariffs 100.00%        
Tariff percentage       130.00%  
Other products          
Concentration risks          
Aggregate dollar amount of net sales   $ 11,460 $ 11,419 $ 38,274 $ 36,785
Tariff percentage       30.00%  
Net Sales | Customer Concentration Risk          
Concentration risks          
Number of significant customers | customer   3 2 3 3
Net Sales | Customer Concentration Risk | Significant customers          
Concentration risks          
Aggregate dollar amount of net sales   $ 5,800,000 $ 5,500,000 $ 16,100,000 $ 12,800,000
Concentration risk, percentage   57.30% 53.20% 55.90% 53.40%
Cost of Sales, Manufacturing | Supplier Concentration Risk | China          
Concentration risks          
Concentration risk, percentage   60.20% 87.30% 61.70% 90.00%